Seer, Inc. is a life sciences company. The Company is engaged in developing transformative products that open a new gateway to the proteome. Its product, the Proteograph Product Suite (Proteograph), leverages its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access to the proteome. The Proteograph Product Suite is an integrated solution that includes consumables, an automation instrument and software. Its proprietary engineered NPs provide unbiased sampling of intact proteins across the dynamic range of the proteome, capturing molecular information at the peptide-level, including protein variants. It is focused on driving the adoption of the Proteograph by customers in the proteomics and genomics markets. The Proteograph Product Suite is an integrated solution consisting of consumables, an automation instrument, and software to perform biased, deep proteomic analysis at scale in a matter of hours.
Código da empresaSEER
Nome da EmpresaSeer Inc
Data de listagemDec 04, 2020
CEODr. Omid C. Farokhzad, M.D.
Número de funcionários134
Tipo de títulosOrdinary Share
Fim do ano fiscalDec 04
Endereço3800 Bridge Parkway, Suite 102
CidadeREDWOOD CITY
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal94065
Telefone16504530000
Sitehttps://seer.bio/
Código da empresaSEER
Data de listagemDec 04, 2020
CEODr. Omid C. Farokhzad, M.D.
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.

Sem dados